<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459905/bin/fonc-11-729106-g002.jpg"/> </div> <div class="text-side"> <h1>Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia.</h1> <p>Immunohistochemical analysis of mixed-infiltrate type A lymphomatoid papulosis (LyP). The punch biopsy from the left arm identified a diffuse infiltration of small lymphocytes and few large-sized Hodgkin-like cells that were prevalent in the dermis and subcutis, while largely sparing the epidermis (A, original magnification, ×10). Hodgkin-like cells stained positive for CD30 (B, original magnification, ×10; and B, inset, original magnification, ×40) and were interspersed in a dense lymphoid infiltrate mostly contributed by CD3+ T cells (C, original magnification, ×10). The expression of the anti-apoptotic protein BCL2 was strong and pervasive in the LyP tissue (D, original magnification, ×10), and it was readily recognized in the reactive lymphoid meshwork and large-sized Hodgkin-like cells (D, inset, black arrow, original magnification, ×40).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34568060/" target="_blank">34568060</a></p><p>Type: Premalignant/Malignant, Category: Hematolymphoid</p>
</div> </div></div></body></html>